Related Experiment Video

Updated: Feb 8, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.8K

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Diagnosis and Considerations for Management

Monica Patten1, Simon Pecha2, Ali Aydin3

  • 1Department of General Cardiology, University Heart Center Hamburg, Hamburg, Germany.

Journal of Atrial Fibrillation
|July 11, 2018
PubMed

Insights

Atrial fibrillation (AF) affects 22-32% of hypertrophic cardiomyopathy (HCM) patients. Early detection and effective treatments, including anticoagulation and ablation, are crucial for managing AF in HCM.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Genetics

Background:

  • Atrial fibrillation (AF) is a frequent complication in hypertrophic cardiomyopathy (HCM), impacting patient outcomes.
  • The prevalence of AF in HCM ranges from 22% to 32%.

Purpose of the Study:

  • To review the incidence, pathophysiology, and clinical manifestations of AF in HCM.
  • To highlight the importance of early AF detection and monitoring strategies.
  • To discuss current and emerging therapeutic options for AF in HCM patients.

Main Methods:

  • Literature review of studies on atrial fibrillation in hypertrophic cardiomyopathy.
  • Analysis of epidemiological data, pathophysiological mechanisms, and clinical presentations.
  • Evaluation of diagnostic monitoring techniques and treatment modalities.

Main Results:

  • Atrial fibrillation significantly impacts survival, left ventricular function, and quality of life in HCM patients.
  • Early recognition through appropriate monitoring is essential for timely intervention.
  • Effective management includes oral anticoagulation and consideration of catheter-based ablation.

Conclusions:

  • Atrial fibrillation is a critical determinant of prognosis in hypertrophic cardiomyopathy.
  • Integrated management strategies incorporating early detection and tailored therapies are vital.
  • Interventional approaches like catheter ablation offer promising therapeutic avenues for AF in HCM.

Keywords:
Atrial FibrillationDevice TherapyEpidemiologyHypertrophic CardiomyopathyImplantable Cardioverter Defibrillator

More Related Videos

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.2K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
506
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
358
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
361